Search the Newsreel

Phibro Animal Health (NASDAQ: PAHC) awards 1,503 RSUs to VP Finance

Phibro Animal Health Corp (NASDAQ: PAHC) has awarded its VP Finance and Treasurer, Patrick Rodriguez, 1,503 restricted stock units (RSUs) representing Class A Common Stock. These RSUs will vest in substantially equal installments over the first three anniversaries of August 1, 2026, contingent on …

Phibro Animal Health (PAHC) grants 12,103 RSUs to Executive Chairman Bendheim

Phibro Animal Health Corp. (PAHC) Executive Chairman and 10% owner Jack Bendheim was granted 12,103 restricted stock units (RSUs). These RSUs, each representing one share of Class A Common Stock, will vest in equal installments over the first three anniversaries of August 1, 2026, …

MiniMed Group (Nasdaq:MMED) - Stock Analysis

This stock analysis report for MiniMed Group (Nasdaq:MMED) provides an overview of the company's financial health, future growth prospects, past performance, and valuation. It highlights recent news including the launch of new insulin pump systems, board changes, and financial results, noting the company is …

LİNK BİLGİSAYAR SİSTEMLERİ YAZILIMI VE DONANIMI SANAYİ VE TİCARET A.Ş. Sorumluluk Beyanı (Konsolide Olmayan) 10 Ağustos 2026

BofA Securities Adjusts MiniMed Group Price Target to $24 From $20

BofA Securities has raised its price target for MiniMed Group (MMED) shares to $24 from $20. This adjustment follows UBS initiating coverage on MiniMed Group with a Buy rating and a $25 price target on July 29th. MiniMed Group, a medical technology company specializing …

BofA raises MiniMed Group stock price target to $24 on exchange timing

BofA Securities has raised its price target for MiniMed Group (NASDAQ: MMED) shares to $24 from $20, while maintaining a Buy rating. The increase is attributed to the approaching potential window for Medtronic to exchange its 90% ownership in MiniMed Group for Medtronic shares. …

YPF Sociedad Anónima (YPF) Earnings Date and Reports 2026 $YPF

YPF Sociedad Anónima (NYSE:YPF) Given Consensus Rating of "Hold" by Brokerages

YPF Sociedad Anónima (NYSE:YPF) has received a consensus "Hold" rating from five brokerage firms, with three recommending a hold and two a buy. The average 12-month price target is $46.00, which is below its current share price of $49.20. Despite beating Q1 earnings expectations, …

Elanco Animal Health Number of Employees 2026 | Employee Count & Headcount Data

Elanco Animal Health (ELAN) had approximately 10,025 employees worldwide as of March 2026, marking a 2.8% growth since 2023. The company is actively hiring, with 772 job postings in 2026, a 40.1% increase from 2025. Its workforce is primarily concentrated in North America, and …

Does Elanco (ELAN) Have a Durable Edge in Animal Health After Its Screwworm EUA Win?

Elanco Animal Health (ELAN) reported stronger Q2 sales and net income, along with an FDA Emergency Use Authorization for its CLiK Extra screwworm-prevention spray. The company also raised its full-year revenue guidance, positioning it as a key player in addressing the New World screwworm …

Elanco Animal Health (ELAN) Following FDA Emergency Use Authorization Has Valuation Back In Focus

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Elanco Animal Health (ELAN) is back in focus after receiving U.S. Food and Drug Administration Emergency Use Authorization for CLiK Extra wound spray, …

Is Elanco Animal Health (ELAN) Undervalued Following Its FDA Emergency Use Authorization?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Elanco Animal Health (ELAN) is back in focus after receiving U.S. Food and Drug Administration Emergency Use Authorization for CLiK Extra wound spray, …

Noticias de acciones de IRSA Inversiones y Representaciones SA (IRS)

Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Recommendation of "Moderate Buy" from Brokerages

Elanco Animal Health (NYSE:ELAN) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $29.09, significantly above its current share price of $22.06. The company recently surpassed quarterly earnings expectations, reporting adjusted EPS of $0.34 on revenues of …

Elanco Animal Health Q2 Earnings Call Highlights

Key Points Interested in Elanco Animal Health Incorporated? Here are five stocks we like better. Strong Q2 performance: Elanco reported revenue of $1.368 billion, up 10% year over year, while adjusted EBITDA rose 21% to $288 million and adjusted EPS increased 31% to $0.34. …

elanco animal health inc. Positive Earnings Pre-Announcements

Elanco Animal Health Inc. (ELAN) has pre-announced positive earnings for FY26, with an updated estimated range of $5.090-$5.140 Billion, up from $5.010-$5.085 Billion. This follows a recent boost in their FY26 outlook and a 7% stock increase reported on August 5, 2026. The company …

Noticias de acciones de Empresa Distribuidora y Comercializadora Norte SA (EDN)

Sonim Technologies Inc (SONM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Sonim Technologies Inc (SONM), including future EPS and revenue growth estimates. It presents financial data such as current stock price, market capitalization, and a peer comparison with other companies like Apple Inc and Tapestry Inc. The content …

Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species

Vigilance and early intervention are key to minimizing animal injury and limiting the parasite's spread, according to Elanco's technical experts Emergency Use Authorization for Elanco's CLiK Extra provides livestock producers with a vital tool in the prevention of New World screwworm infestations. Elanco also …

Informe de resultados: Loma Negra decepciona en el Q2 2026 y sus acciones caen

Elanco Ends Lobbying Relationship With Stumptown Strategies

Elanco Animal Health Inc. has terminated its lobbying contract with Stumptown Strategies LLC, a firm it paid approximately $10,000 per quarter. The company, which had Blair Larkins as its primary lobbyist, has been advocating for the Innovative FEED Act, legislation aimed at reclassifying certain …

Elanco granted FDA’s emergency nod for new world screwworm drug

[US Food and Drug Administration (FDA)] * The U.S. Food and Drug Administration has granted an emergency use authorization for Elanco Animal Health’s (ELAN [https://seekingalpha.com/symbol/ELAN]) antiparasitic therapy CLiK Extra as a treatment to prevent new world screwworm infestations. * The authorization came after the …

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

EURO MENKUL KIYMET YATIRIM ORTAKLIĞI A.Ş.(EUYO) Sorumluluk Beyanı (Konsolide Olmayan) 6 Ağustos 2026

Amundi Has $2.35 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN

Phibro Animal Health (PAHC) CFO sells 840 shares to cover taxes

Phibro Animal Health's CFO, David Glenn, disposed of 840 shares of Class A Common Stock on August 4, 2026, at an average price of $36.599 per share. This transaction was a broker-assisted cashless exercise performed to satisfy tax withholding obligations related to the vesting …

Phibro Animal Health (NASDAQ: PAHC) COO sells 635 shares for tax withholding

Phibro Animal Health's Chief Operating Officer, Larry Lee Miller, sold 635 shares of Class A Common Stock on August 4, 2026, at a price of $36.599 per share. This transaction was a broker-assisted cashless exercise to cover tax withholding obligations associated with the vesting …

Phibro Animal Health (NASDAQ: PAHC) GC sells 472 shares for taxes

Phibro Animal Health's General Counsel, Judith Weinstein, sold 472 shares of Class A Common Stock on August 4, 2026, at $36.599 per share. This transaction was a broker-assisted cashless exercise to cover tax withholding obligations upon the vesting of restricted stock units. Following this …

Elanco Animal Health Inc (ELAN) Shares Fall 7.7% -- What GF Score of 66 Tells Investors

Elanco Animal Health Inc (ELAN) shares recently fell 7.7% to $24.20, making it 8.5% down for the week. The stock is currently deemed significantly overvalued with a GF Value™ of $15.62, despite having an above-average GF Score™ of 66/100. While insider activity shows purchases, …

Elanco CEO on Boosted Forecast, Surge in Tick Bites

Elanco Animal Health President and CEO Jeff Simmons discusses what's behind the company's increased profit and revenue forecasts. Speaking on "Bloomberg The Close," Simmons also comments on the recent surge in tick bites and consumer spending on pet health products. View Comments

Elanco raises 2026 outlook after strong second-quarter results

Elanco Animal Health Inc. reported a 10% increase in second-quarter revenue to $1.37 billion, leading the company to raise its full-year financial guidance for the second time. The growth was attributed to strong performance of new products like Zenrelia and Credelio Quattro, as well …

FMR LLC discloses 15% ownership of Phibro Animal Health (PAHC) Class A shares

FMR LLC and Abigail P. Johnson have reported a 15.0% beneficial ownership stake in Phibro Animal Health Corp's Class A common stock, totaling 3,160,280.92 shares as of June 30, 2026. FMR LLC holds sole voting power over 3,159,853 shares and sole dispositive power over …

Why Elanco Animal Health (ELAN) Stock Is Down Today

ADUS vs. ELAN: Which Stock Is the Better Value Option?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Elanco Animal Health Incorporated (ELAN). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take …

UBS Adjusts Price Target on Elanco Animal Health to $33 From $31, Maintains Buy Rating

UBS has increased its price target for Elanco Animal Health to $33 from $31, while reiterating a Buy rating on the stock. This adjustment follows Elanco's Q2 2026 earnings call, where the company reported rising adjusted earnings and revenue and lifted its 2026 outlook. …

MiniMed Group (NASDAQ: MMED) says General Counsel Courtney Nelson Wills will step down

MiniMed Group (NASDAQ: MMED) announced that its Senior Vice President, General Counsel, and Corporate Secretary, Courtney Nelson Wills, will resign effective September 25, 2026. Ms. Wills notified the company on July 30, 2026, and her departure is due to personal reasons, as she has …